pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Multiple logistic regression analysis of migraine prophylactic drug utilization

Odds Ratio (OR) 95% CI p-Value

Total (N=534)
Age group <40 Reference
40-49 0.695 0.425-1.133 0.146
≥50 0.513 0.302-0.862 0.012
Sex Male Reference
Female 1.606 0.988-2.649 0.059
Insurance type NHI Reference
MedAid/PVI 0.608 0.198-1.736 0.362
Migraine without aura Reference
Migraine type Migraine with aura 0.657 0.310-1.371 0.266
Other migraine 0.471 0.316-0.700 <0.001
Comorbidities Epilepsy 7.326 2.586-26.488 <0.001
Depressive disorders 2.439 1.567-3.827 <0.001
Insomnia 1.266 0.709-2.265 0.425
Hypertension 1.085 0.640-1.834 0.761
Diabetes mellitus 1.119 0.580-2.163 0.736
Dyslipidemia 1.532 0.947-2.488 0.083
Osteoarthritis 1.467 0.951-2.268 0.083
Rheumatoid arthritis 1.359 0.553-3.282 0.496
Asthma 1.226 0.712-2.107 0.460
Thyroid gland disorders 0.687 0.406-1.149 0.157
c-statistic 0.713
p value of Hosmer-Lemeshow test 0.703

NHI, national health insurance; MedAid, medical aid; PVI, patriots & veterans insurance; COPD, chronic obstructive pulmonary disease

Korean J Clin Pharm 2021;31:35-43 https://doi.org/10.24304/kjcp.2021.31.1.35
© 2021 Korean J Clin Pharm